ED
The startup develops molecular diagnostic tests utilizing epigenetic analysis to quantify immune cells from a single drop of blood collected via finger-prick. This method enables early detection and monitoring of treatable immune system disorders, facilitating timely intervention for patients.
Updated 3 months ago
Funding
$520K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops molecular diagnostic tests utilizing epigenetic analysis to quantify immune cells from a single drop of blood collected via finger-prick. This method enables early detection and monitoring of treatable immune system disorders, facilitating timely intervention for patients.